CLINICAL TRIALS PROFILE FOR BRETHINE
✉ Email this page to a colleague
All Clinical Trials for BRETHINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00607503 ↗ | A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 | 2008-02-01 | The purpose of the study is to gain experience with the use of terbutaline in children with T1D and to determine that there is not a frequent serious, unexpected, uncontrollable effect on short-term glycemic control. Some information also will be obtained with regard to whether terbutaline, in the dosing being used in the study, is sufficiently well tolerated to expect that adherence will be satisfactory in a large randomized trial. In addition, this pilot study will provide data on the accuracy of a continuous glucose monitor during terbutaline use to verify that the drug does not impact on sensor function. |
| NCT00607503 ↗ | A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes | Completed | Jaeb Center for Health Research | Phase 1 | 2008-02-01 | The purpose of the study is to gain experience with the use of terbutaline in children with T1D and to determine that there is not a frequent serious, unexpected, uncontrollable effect on short-term glycemic control. Some information also will be obtained with regard to whether terbutaline, in the dosing being used in the study, is sufficiently well tolerated to expect that adherence will be satisfactory in a large randomized trial. In addition, this pilot study will provide data on the accuracy of a continuous glucose monitor during terbutaline use to verify that the drug does not impact on sensor function. |
| NCT02115256 ↗ | Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline | Terminated | Yaakov Beilin | Phase 2/Phase 3 | 2014-07-01 | Breech presentation of a term pregnancy is a common occurrence. A procedure known as external cephalic version (ECV) is frequently used by obstetricians to turn the baby into the vertex position prior to delivery in order to avoid a cesarean section and the associated risks. Medications to relax the uterus, known as tocolytics, are used in conjunction with the procedure as they have been shown to improve the success rate of ECV, but with inconsistent, varying results. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BRETHINE
Condition Name
Clinical Trial Locations for BRETHINE
Trials by Country
Clinical Trial Progress for BRETHINE
Clinical Trial Phase
Clinical Trial Sponsors for BRETHINE
Sponsor Name
